Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2023 Nov 6;16(12):e010516. doi: 10.1161/CIRCOUTCOMES.123.010516

Table 3:

Healthcare access and cardiovascular risk factor management among low-income working-age US adults by Medicaid expansion status, 2021 vs 2019

Measure Medicaid Expansion Status Weighted % (95% CI) Unadjusted relative risk (reference: 2019) Adjusted relative risk *(reference: 2019) p-value of interaction term
2019 2021
Healthcare access
Had some form of health insurance Non-expansion 58.7
(56.7,60.6)
64.0
(61.5,66.4)
1.09
(1.07,1.11)
1.08
(1.06,1.10)
0.34
Expansion 76.5
(75.6,77.4)
83.2
(82.1,84.3)
1.12
(1.05,1.17)
1.11
(1.05,1.17)
Able to identify a personal health care provider Non-expansion 56.4
(54.4,58.4)
64.5
(62.1,67.0)
1.11
(1.08,1.13)
1.09
(1.07,1.12)
0.10
Expansion 65.7
(64.7,66.7)
72.2
(70.9,73.6)
1.13
(1.06,1.20)
1.15
(1.09,1.21)
Able to afford care visits (i.e., did not skip a visit due to cost in the last 12 months) Non-expansion 64.5
(62.6,66.3)
69.3
(67.1,71.6)
1.05
(1.03,1.08)
1.05
(1.03,1.07)
0.16
Expansion 78.0
(77.1,78.8)
81.8
(80.8,82.9)
1.10
(1.04,1.14)
1.09
(1.04,1.14)
Had a check-up within the last 12 months Non-expansion 67.4
(65.6,69.3)
64.1
(61.7,66.6)
0.97
(0.94,0.99)
0.95
(0.92,0.98)
0.38
Expansion 71.6
(70.6,72.5)
67.7
(66.3,69.1)
0.97
(0.92,1.01)
0.97
(0.93,1.02)
Cardiovascular Risk Management
Cholesterol check Non-expansion 59.7
(57.6,61.7)
55.4
(52.8,57.9)
0.93
(0.90,0.96)
0.92
(0.90,0.95)
0.45
Expansion 59.3
(58.2,60.4)
53.9
(52.4,55.5)
0.97
(0.91,1.00)
0.95
(0.90,1.00)
Test for diabetes|| Non-expansion 47.4
(45.1,49.8)
45.7
(42.3,49.2)
0.94
(0.88,0.99)
0.93
(0.88,0.99)
0.02
Expansion 51.3
(49.4,53.3)
45.7
(43.4,47.9)
1.06
(0.96,1.15)
1.06
(0.97,1.16)
Taking prescribed medication for high blood pressure# Non-expansion 67.5
(64.8,70.2)
69.1
(65.4,72.8)
1.04
(1.01,1.09)
1.04
(1.00,1.09)
0.77
Expansion 63.3
(61.5,65.2)
64.4
(61.9,66.8)
1.06
(1.00,1.11)
1.06
(0.99,1.12)
Taking insulin for diabetes** Non-expansion 35.2
(28.7,41.8)
40.0
(33.2,46.7)
1.02
(0.86,1.21)
1.02
(0.86,1.21)
0.88
Expansion 37.8
(34.1,41.5)
39.9
(35.0,44.7)
1.00
(0.78,1.26)
1.00
(0.77,1.29)
At least one visit for known diabetes*** Non-expansion 85.7
(80.3,91.0)
88.3
(84.1,92.4)
1.01
(0.96,1.05)
1.00
(0.95,1.04)
0.25
Expansion 89.3
(87.0,91.5)
88.3
(85.5,91.2)
1.02
(0.95,1.13)
1.04
(0.97,1.12)

Nationally-representative estimates (%) are shown after the application of BRFSS weights, unless otherwise specified.

*

Survey-weighted Poisson regression model that adjusts for age, sex, asthma, chronic obstructive pulmonary disease, depressive disorder, non-skin cancer, kidney disease, myocardial infarction, stroke, coronary artery disease, hypertension, hyperlipidemia, and diabetes. The year 2019 is the reference group

Assesses whether there was a differential change in the outcome of interest among low-income adults residing in Medicaid expansion versus non-expansion states in 2021 versus 2019

Participants were asked if they had a cholesterol check in the past year

||

Participants without diabetes were asked if they had a test for diabetes in the past three years

#

Among participants with high blood pressure

**

. Among participants with diabetes

***

. Participants with diabetes were asked if they had a visit in the past year